M A Quinn-Allen - JoVE Visualize

Showing results (1-10 of 14) with videos related to

Pageof 2

Sort By:

Journal of Thrombosis and Haemostasis : JTH|January 27, 2005

Mutation of hydrophobic residues in the factor Va C1 and C2 domains blocks membrane-dependent prothrombin activationW Peng, M A Quinn-Allen, W H Kane

Cancer|April 1, 1992

Human melanoma-mediated inhibition of autologous CD4+ helper tumor-infiltrating lymphocyte growth in vitroT L Darrow, Z Wahab, M A Quinn-Allen, et al.

Biochemistry|March 28, 1995

Thrombin-catalyzed activation of recombinant human factor VF G Keller, T L Ortel, M A Quinn-Allen, et al.

Cellular Immunology|August 25, 1996

Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2T L Darrow, Z Abdel-Wahab, M A Quinn-Allen, et al.

Cellular Immunology|February 1, 1990

Modulation of in vitro autologous melanoma-specific cytotoxic T-cell responses by phorbol dibutyrate and ionomycinT L Darrow, M A Quinn-Allen, N J Crowley, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991

MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A alleleN J Crowley, T L Darrow, M A Quinn-Allen, et al.

Journal of the National Cancer Institute|September 7, 1988

Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive casesC L Slingluff, T Darrow, C Vervaert, et al.

Biochemistry|July 11, 2001

Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor VaA Srivastava, M A Quinn-Allen, S W Kim, et al.

The Journal of Clinical Investigation|December 1, 1992

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activityT L Ortel, M A Quinn-Allen, L A Charles, et al.

The Journal of Biological Chemistry|June 3, 1994

Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimerasT L Ortel, M A Quinn-Allen, F G Keller, et al.

Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:

Pageof 2

Journal of Thrombosis and Haemostasis : JTH|January 27, 2005

Mutation of hydrophobic residues in the factor Va C1 and C2 domains blocks membrane-dependent prothrombin activationW Peng, M A Quinn-Allen, W H Kane

Cancer|April 1, 1992

Human melanoma-mediated inhibition of autologous CD4+ helper tumor-infiltrating lymphocyte growth in vitroT L Darrow, Z Wahab, M A Quinn-Allen, et al.

Biochemistry|March 28, 1995

Thrombin-catalyzed activation of recombinant human factor VF G Keller, T L Ortel, M A Quinn-Allen, et al.

Cellular Immunology|August 25, 1996

Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2T L Darrow, Z Abdel-Wahab, M A Quinn-Allen, et al.

Cellular Immunology|February 1, 1990

Modulation of in vitro autologous melanoma-specific cytotoxic T-cell responses by phorbol dibutyrate and ionomycinT L Darrow, M A Quinn-Allen, N J Crowley, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991

MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A alleleN J Crowley, T L Darrow, M A Quinn-Allen, et al.

Journal of the National Cancer Institute|September 7, 1988

Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive casesC L Slingluff, T Darrow, C Vervaert, et al.

Biochemistry|July 11, 2001

Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor VaA Srivastava, M A Quinn-Allen, S W Kim, et al.

The Journal of Clinical Investigation|December 1, 1992

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activityT L Ortel, M A Quinn-Allen, L A Charles, et al.

The Journal of Biological Chemistry|June 3, 1994

Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimerasT L Ortel, M A Quinn-Allen, F G Keller, et al.

Pageof 2